The atypical antipsychotic Risperdal continues to fuel litigation, as scores of male patients claim they developed breasts after taking the drug as children and adolescents. Court dockets indicate some 500 Risperdal lawsuits pending against pharmaceutical giant Johnson & Johnson, which has already settled a handful of claims (under confidential terms)... Read more »